Advanced in vitro systems for efficacy and toxicity testing in nanomedicine

European Journal of Nanomedicine

Volumn 6, Issue 3, 2014, Pages 171-183

  Fabbrizi, Maria Rita ^a   Duff, Tracey ^a   Oliver, Jo ^a   Wilde, Colin ^a  

^a AvantiCell Science Ltd   (United Kingdom)

Author keywords

cell based systems; commercial platforms; nanosafety

Indexed keywords

ARCHITECTURE; ASSEMBLY; CELL CULTURE; CELL PROLIFERATION; CELLS; HISTOLOGY; MEDICAL NANOTECHNOLOGY; TISSUE;

CELL-BASED; CLINICAL PERFORMANCE; COMMERCIAL PERSPECTIVES; COMMERCIAL PLATFORMS; EPITHELIAL MONOLAYERS; NANOSAFETY; THERAPEUTIC BENEFITS; THERAPEUTIC STRATEGY;

SCAFFOLDS (BIOLOGY);

NANOPARTICLE; POLYSTYRENE; QUANTUM DOT; SILICON DIOXIDE; SILVER NANOPARTICLE; ZINC OXIDE;

ADHERENT CELL; ATOMIC FORCE MICROSCOPY; BLOOD BRAIN BARRIER; CAPILLARY ENDOTHELIAL CELL; CELL AGGREGATION; CELL ANCHORAGE; CELL COMMUNICATION; CELL CULTURE; CELL TYPE; COCULTURE; CULTURE VESSEL; CYTOLYSIS; CYTOTOXICITY; DENDRITIC CELL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMMORTALIZED CELL LINE; IN VITRO STUDY; MACROPHAGE; MICROENVIRONMENT; NANOMEDICINE; NANOTOXICOLOGY; NONHUMAN; PERICYTE; PHENOTYPE; PRIMARY CELL CULTURE; PRIMARY CELL LINE; REVIEW; THREE DIMENSIONAL CELL CULTURE; TUMOR SPHEROID; TWO DIMENSIONAL CELL CULTURE;

EID: 84907528454     PISSN: 16625986     EISSN: 1662596X     Source Type: Journal    
DOI: 10.1515/ejnm-2014-0018     Document Type: Review

References (157)

1. Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med 2010;363:2434-43.
2. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60.
3. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: Therapeutic applications and developments. Clin Pharmacol Ther 2008;83:761-9.
4. Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. Nanomedicine -challenge and perspectives. Angew Chem Int Ed Engl 2009;48:872-97.
5. Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 2012;41:2885-911.
6. Nel AE. Alternative test strategies for engineered nanomaterials. J Intern Med 2013;274:561-77.
7. Sanna V, Pala N, Sechi M. Targeted therapy using nanotechnology: focus on cancer. Int J Nanomed 2014;9:467-83.
8. Huang L, Reebye S, Yeung A, Jia W, Skarsgard E. Lentiviral-mediated fetal gene therapy for monogenic disorders: development of an in vitro rabbit model. Fetal Diagn Ther 2006;21:241-5.
9. Quinlan J, Yu W, Hornsey M, Tosh D, Slack J. In vitro culture of embryonic mouse intestinal epithelium: cell differentiation and introduction of reporter genes. BMC Dev Biol 2006;6:24.
10. Torche A, Jouan H, Le Corre P, Albina E, Primault R, Jestin A, et al. Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyers patch segment. Int J Pharm 2000;201:15-27.
11. Lang D, Droemann D, Schultz H, Branscheid D, Martin C, Ressmeyer A, et al. A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy. Respiratory Res 2007;8:43.
12. Rovida C, De Angelis I, Lorenzetti S. Alternative in vitro methods to characterize the role of Endocrine Active Substances (EASs) in hormone-targeted tissues. ALTEX 2013;30:253-5.
13. Huang K, Ma H, Liu J, Huo S, Kumar A, Wei T, et al. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano 2012;6:4483-93.
14. Valencia PM, Pridgen EM, Rhee M, Langer R, Farokhzad OC, Karnik R. Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy. ACS Nano 2013;7:10671-80.
15. Lau TT, Peck Y, Huang W, Wang DA. Optimization of chondrocyte isolation and phenotype characterization for cartilage tissue engineering. Tissue Eng Part C Methods 2014. Epub ahead of print. doi: 10.1089/ten.TEC.2014.0159.
16. Lopez AD, Kayali AG, Hayek A, King CC. Isolation, culture, and imaging of human fetal pancreatic cell clusters. J Vis Exp 2014;87:e50796.
17. Mattinzoli D, Messa P, Corbelli A, Ikehata M, Mondini A, Zennaro C, et al. Application of retinoic acid to obtain osteocytes cultures from primary mouse osteoblasts. J Vis Exp 2014;87:e51465.
18. Zhou L, Sohet F, Daneman R. Purification and culture of central nervous system pericytes. Cold Spring Harb Protoc 2014;2014:pdb.top070888.
19. Busser H, De Bruyn C, Urbain F, Najar M, Pieters K, Raicevic G, et al. Isolation of adipose derived stromal cells without enzymatic treatment: expansion, phenotypical and functional characterization. Stem Cells Dev 2014. Epub ahead of print. doi: 10.1089/scd.2014.0071.
20. Taylor SE, Clegg PD. Collection and propagation methods for mesenchymal stromal cells. Vet Clin North Am Equine Pract 2011;27:263-74.
21. Lerescu L, Tucureanu C, Caraş I, Neagu S, Melinceanu L, Sələgeanu A. Primary cell culture of human adenocarcinomas -practical considerations. Roum Arch Microbiol Immunol 2008;67:55-66.
22. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008;197: 496-503.
23. Holdsworth SR, Glasgow EF, Atkins RC, Thomson NM. Cell characteristics of cultured glomeruli from different animal species. Nephron 1978;22:454-9.
24. Kang T, Gao X, Hu Q, Jiang D, Feng X, Zhang X, et al. iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas. Biomaterials 2014;pii: S0142-9612(14)00126-4.
25. Welsher K, Yang H. Multi-resolution 3D visualization of the early stages of cellular uptake of peptide-coated nanoparticles. Nat Nanotechnol 2014;9:198-203.
26. Mishra BJ, Kaul A, Trivedi P. I-Cysteine conjugated poly l-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo. Drug Deliv 2014. doi: 10.3109/10717544.2014.883117.
27. Voigt J, Christensen J, Shastri VP. Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae. Proc Natl Acad Sci USA 2014;111:2942-7.
28. Rouhani H, Sepehri N, Montazeri H, Khoshayand MR, Ghahremani MH, Ostad SN, et al. Zinc protoporphyrin polymeric nanoparticles: potent heme oxygenase inhibitor for cancer therapy. Pharm Res 2014. doi: 10.1007/s11095-014-1313-7.
29. Kang SJ, Lee YJ, Lee EK, Kwak MK. Silver nanoparticles-mediated G2/M cycle arrest of renal epithelial cells is associated with NRF2-GSH signaling. Toxicol Lett 2012;211:334-41.
30. Waters KM, Masiello LM, Zangar RC, Tarasevich BJ, Karin NJ, Quesenberry RD, et al. Macrophage responses to silica nanoparticles are highly conserved across particle sizes. Toxicol Sci 2009;107:553-69.
31. Di Bucchianico S, Fabbrizi MR, Cirillo S, Uboldi C, Gilliland D, Valsami-Jones E, et al. Aneuploidogenic effects and DNA oxidation induced in vitro by differently sized gold nanoparticles. International Journal of Nanomedicine 2014;9:2191-204.
32. Tripathy N, Hong TK, Ha KT, Jeong HS, Hahn YB. Effect of ZnO nanoparticles aggregation on the toxicity in RAW 264.7 murine macrophage. J Hazard Mater 2014;270C:110-7.
33. Sahu D, Kannan GM, Vijayaraghavan R. Size-dependent effect of zinc oxide on toxicity and inflammatory potential of human monocytes. J Toxicol Environ Health A 2014;77:177-91.
34. Gliga AR, Skoglund S, Odnevall Wallinder I, Fadeel B, Karlsson HL. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: The role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol 2014;11:11.
35. Demir E, Akça H, Kaya B, Burgucu D, Tokgün O, Turna F, et al. Zinc oxide nanoparticles: genotoxicity, interactions with UV-light and cell-transforming potential. J Hazard Mater 2014;264:420-9.
36. Sahu SC, Zheng J, Graham L, Chen L, Ihrie J, Yourick JJ, et al. Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture. J Appl Toxicol 2014. doi: 10.1002/jat.2994.
37. Frenzilli G, Bernardeschi M, Guidi P, Scarcelli V, Lucchesi P, Marsili L, et al. Effects of in vitro exposure to titanium dioxide on DNA integrity of bottlenose dolphin (Tursiops truncatus) fibroblasts and leukocytes. Mar Environ Res 2014;pii: S0141-1136(14)00010-5.
38. Di Bucchianico S, Fabbrizi MR, Misra SK, Valsami-Jones E, Berhanu D, Reip P, et al. Multiple cytotoxic and genotoxic effects induced in vitro by differently shaped copper oxide nanomaterials. Mutagenesis 2013;28:287-99.
39. Deng X, Cao M, Zhang J, Hu K, Yin Z, Zhou Z, et al. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Biomaterials 2014;pii:S0142-9612(14)00132-X.
40. Tavassolian F, Kamalinia G, Rouhani H, Amini M, Ostad SN, Khoshayand MR, et al. Targeted poly (l-Ã-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells. Int J Pharm 2014;467:123-38.
41. Chiu RY, Tsuji T, Wang SJ, Wang J, Liu CT, Kamei DT. Improving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targeting. J Control Release 2014;pii: S0168-3659(14)00066-2.
42. Kuo YC, Hong TY. Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline. Int J Pharm 2014;pii: S0378-5173(14)00090-8.
43. Amjadi I, Rabiee M, Hosseini MS. Anticancer activity of nanoparticles based on PLGA and its co-polymer: in-vitro evaluation. Iran J Pharm Res 2013;12:623-34.
44. Li K, Liu G, Wu Y, Hao P, Zhou W, Zhang Z. Gold nanoparticle amplified optical microfiber evanescent wave absorption biosensor for cancer biomarker detection in serum. Talanta 2014;120:419-24.
45. Zhao Y, Ji T, Wang H, Li S, Zhao Y, Nie G. Self-Assembled peptide nanoparticles as tumor microenvironment activatable probes for tumor targeting and imaging. J Control Release 2014;177C:11-9.
46. John W. Haycock. 3D cell culture: A review of current approaches and techniques. Methods Mol Biol 2011;695:1-15.
47. Pan C, Kumar C, Bohl S, Klingmueller U, Mann M. Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type-specific functions. Mol Cell Proteomics 2009;8:443-50.
48. Cheng M, Gao X, Wang Y, Chen H, He B, Li Y, et al. Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo. Int J Nanomed 2013;8:4265-76.
49. Xiang D, Zheng Y, Duan W, Li X, Yin J, Shigdar S, et al. Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int J Nanomed 2013;8:4103-13.
50. Qiao C, Zhang K, Jin H, Miao L, Shi C, Liu X, et al. Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo. Int J Nanomed 2013;8:2985-95.
51. Saremi S, Dinarvand R, Kebriaeezadeh A, Ostad SN, Atyabi F. Enhanced oral delivery of docetaxel using thiolated chitosan nanoparticles: preparation, in vitro and in vivo studies. Biomed Res Int 2013;2013:150478.
52. Fan L, Cheng C, Qiao Y, Li F, Li W, Wu H, et al. GNPs-CS/KGM as hemostatic first aid wound dressing with antibiotic effect: in vitro and in vivo study. PLoS One 2013;8:e66890.
53. Su B, Peng X, Jiang D, Wu J, Qiao B, Li W, et al. In vitro and in vivo evaluations of nano-hydroxyapatite/polyamide 66/glass fibre (n-HA/PA66/GF) as a novel bioactive bone screw. PLoS One 2013;8:e68342.
54. Li K, Chen B, Xu L, Feng J, Xia G, Cheng J, et al. Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivo. Int J Nanomed 2013;8:1867-77.
55. Wang M, Zhang Y, Feng J, Gu T, Dong Q, Yang X, et al. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4. Int J Nanomed 2013;8:1141-54.
56. Ahn RW, Barrett SL, Raja MR, Jozefik JK, Spaho L, Chen H, et al. Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo. PLoS One 2013;8:e58491.
57. Kudgus RA, Szabolcs A, Khan JA, Walden CA, Reid JM, Robertson JD, et al. Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics. PLoS One 2013;8:e57522.
58. Cifola I, Bianchi C, Mangano E, Bombelli S, Frascati F, Fasoli E, et al. Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues. BMC Cancer 2011;11:244.
59. Wang P, Cong M, Liu TH, Yang AT, Cong R, Wu P, et al. Primary isolated hepatic oval cells maintain progenitor cell phenotypes after two-year prolonged cultivation. J Hepatol 2010;53:863-71.
60. Stansley B, Post J, Hensley K. A comparative review of cell culture systems for the study of microglial biology in Alzheimers disease. J Neuroinflammation 2012;9:115.
61. Sandow SL, Grayson TH. Limits of isolation and culture: intact vascular endothelium and BKCa. Am J Physiol Heart Circ Physiol 2009;297:H1-7.
62. Müller AS, Pallauf J. Effect of increasing selenite concentrations, vitamin E supplementation and different fetal calf serum content on GPx1 activity in primary cultured rabbit hepatocytes. J Trace Elem Med Biol 2003;17:183-92.
63. Wu X, Huang K, Wei C, Chen F, Pan C. Regulation of cellular glutathione peroxidase by different forms and concentrations of selenium in primary cultured bovine hepatocytes. J Nutr Biochem 2010;21:153-61.
64. Zhang J, Wang H, Bao Y, Zhang L. Nano red elemental selenium has no size effect in the induction of seleno-enzymes in both cultured cells and mice. Life Sci 2004;75:237-44.
65. Turkez H, Yousef MI, Sönmez E, Togar B, Bakan F, Sozio P, et al. Evaluation of cytotoxic, oxidative stress and genotoxic responses of hydroxyapatite nanoparticles on human blood cells.J Appl Toxicol 2014;34:373-9.
66. Zhao X, Ng S, Heng BC, Guo J, Ma L, Tan TT, et al. Cytotoxicity of hydroxyapatite nanoparticles is shape and cell dependent. Arch Toxicol 2013;87:1037-52.
67. Wang S, Wen S, Shen M, Guo R, Cao X, Wang J, et al. Aminopropyltriethoxysilane-mediated surface functionalization of hydroxyapatite nanoparticles: synthesis, characterization, and in vitro toxicity assay. Int J Nanomed 2011;6:3449-59.
68. Sun X, Wang Z, Zhai S, Cheng Y, Liu J, Liu B. In vitro cytotoxicity of silver nanoparticles in primary rat hepatic stellate cells. Mol Med Rep 2013;8:1365-72.
69. Kim HR, Kim MJ, Lee SY, Oh SM, Chung KH. Genotoxic effects of silver nanoparticles stimulated by oxidative stress in human normal bronchial epithelial (BEAS-2B) cells. Mutat Res 2011;726:129-35.
70. Gaiser BK, Hirn S, Kermanizadeh A, Kanase N, Fytianos K, Wenk A, et al. Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci 2013;131:537-47.
71. Gao L, Yang ST, Li S, Meng Y, Wang H, Lei H. Acute toxicity of zinc oxide nanoparticles to the rat olfactory system after intranasal instillation. J Appl Toxicol 2013;33:1079-88.
72. Kang T, Guan R, Chen X, Song Y, Jiang H, Zhao J. In vitro toxicity of different-sized ZnO nanoparticles in Caco-2 cells. Nanoscale Res Lett 2013;8:496.
73. Andersson-Willman B, Gehrmann U, Cansu Z, Buerki-Thurnherr T, Krug HF, Gabrielsson S, et al. Effects of subtoxic concentrations of TiO2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol Appl Pharmacol 2012;264:94-103.
74. Sahu D, Kannan GM, Vijayaraghavan R, Anand T, Khanum F. Nanosized zinc oxide induces toxicity in human lung cells. ISRN Toxicol 2013;2013:316075.
75. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010;9:615-27.
76. Hutmacher DW, Loessner D, Rizzi S, Kaplan DL, Mooney DJ, Clements JA. Can tissue engineering concepts advance tumor biology research? Trends Biotechnol 2010;28:125-33.
77. Tibbitt MW, Anseth KS. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 2009;103:655-63.
78. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ, et al. Engineering tumors with 3D scaffolds. Nat Methods 2007;4:855-60.
79. Pagliari S, Tirella A, Ahluwalia A, Duim S, Goumans MJ, Aoyagi T, et al. A multistep procedure to prepare pre-vascularized cardiac tissue constructs using adult stem sells, dynamic cell cultures, and porous scaffolds. Front Physiol 2014;5:210.
80. Lovitt CJ, Shelper TB, Avery VM. Advanced cell culture techniques for cancer drug discovery. Biology (Basel) 2014;3: 345-67.
81. Ekert JE, Johnson K, Strake B, Pardinas J, Jarantow S, Perkinson R, et al. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro -implication for drug development. PLoS One 2014;9:e92248.
82. Fang X, Sittadjody S, Gyabaah K, Opara EC, Balaji KC. Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer. PLoS One 2013;8:e75187.
83. Seras-Franzoso J, Steurer C, Roldn M, Vendrell M, Vidaurre-Agut C, Tarruella A, et al. Functionalization of 3D scaffolds with protein-releasing biomaterials for intracellular delivery. J Control Release 2013;171:63-72.
84. Mitra M, Mohanty C, Harilal A, Maheswari UK, Sahoo SK, Krishnakumar S. A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs. Mol Vis 2012;18:1361-78.
85. Ng CP, Pun SH. A perfusable 3D cell-matrix tissue culture chamber for in situ evaluation of nanoparticle vehicle penetration and transport. Biotechnol Bioeng 2008;99:1490-501.
86. Shi WB, Le VM, Gu CH, Zheng YH, Lang MD, Lu YH, et al. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles. J Pharm Sci 2014;103:1064-74.
87. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature 2004;428:487-92.
88. Lee J, Cuddihy MJ, Kotov NA. Three-dimensional cell culture matrices: state of the art. Tissue Eng Part B Rev 2008;14: 61-86.
89. Yip D, Cho CH. A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing. Biochem Biophys Res 2013;C433:327-32.
90. Shin CS, Kwak B, Han B, Park K. Development of an in vitro 3D tumor model to study therapeutic efficiency of an anticancer drug. Mol Pharm 2013;10:2167-75.
91. Kuo C-T, Chiang C-L, Yun-Ju Huang R, Lee H, Wo AM. Configurable 2D and 3D spheroid tissue cultures on bioengineered surfaces with acquisition of epithelial-mesenchymal transition characteristics. NPG Asia Mater 2012;4:1-8.
92. Chen L, Xiao Z, Meng Y, Zhao Y, Han J, Su G, et al. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials 2012;33:1437-44.
93. Biondi M, Guarnieri D, Yu H, Belli V, Netti PA. Sub-100 nm biodegradable nanoparticles: in vitro release features and toxicity testing in 2D and 3D cell cultures. Nanotechnology 2013;24:045101.
94. Ma HL, Jiang Q, Han S, Wu Y, Cui Tomshine J, Wang D, et al. Multicellular tumor spheroids as an in vivo-like tumor model for three-dimensional imaging of chemotherapeutic and nano material cellular penetration. Mol Imaging 2012;11:487-98.
95. Goodman TT, Olive PL, Pun SH. Increased nanoparticle penetration in collagenase-treated multicellular spheroids. Int J Nanomed 2007;2:265-74.
96. Pampaloni F, Reynaud EG, Stelzer EH. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 2008;8:839-45.
97. Timmins NE, Harding FJ, Smart C, Brown MA, Nielsen LK. Method for the generation and cultivation of functional threedimensional mammary constructs without exogenous extracellular matrix. Cell Tissue Res 2005;320:207-10.
98. Castaneda F, Kinne RK. Short exposure to millimolar concentrations of ethanol induces apoptotic cell death in multicellular HepG2 spheroids. J Cancer Res Clin Oncol 2000;126:305-10.
99. Ivascu A, Kubbies M. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen 2006;11:922-32.
100. Ho VH, Smith MJ, Slater NK. Effect of magnetite nanoparticle agglomerates on the destruction of tumor spheroids using high intensity focused ultrasound. Ultrasound Med Biol 2011;37:169-75.
101. Huo S, Ma H, Huang K, Liu J, Wei T, Jin S, et al. Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors. Cancer Res 2013;73:319-30.
102. Dilnawaz F, Sahoo SK. Enhanced accumulation of curcumin and temozolomide loaded magnetic nanoparticles executes profound cytotoxic effect in glioblastoma spheroid model. Eur J Pharm Biopharm 2013;85:452-62.
103. Hsiao AY, Tung YC, Qu X, Patel LR, Pienta KJ, Takayama S. 384 hanging drop arrays give excellent Z-factors and allow versatile formation of co-culture spheroids. Biotechnol Bioeng 2012;109:1293-304.
104. Tung YC, Hsiao AY, Allen SG, Torisawa YS, Ho M, Takayama S. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 2011;136:473-8.
105. Masuda A, Yasuoka H, Satoh T, Okazaki Y, Yamaguchi Y, Kuwana M. Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop. Arthritis Res Ther 2013;15:R74.
106. Berginc K, Kristl A. Transwell-grown HepG2 cell monolayers as in vitro permeability model to study drug-drug or drug-food interactions. J Med Food 2011;14:135-9.
107. Amann A, Zwierzina M, Gamerith G, Bitsche M, Huber JM, Vogel GF, et al. Development of an innovative 3D cell culture system to study tumour-stroma interactions in non-small cell lung cancer cells. PLoS One 2014;9:e92511.
108. Messner S, Agarkova I, Moritz W, Kelm JM. Multi-cell type human liver microtissues for hepatotoxicity testing. Arch Toxicol 2013;87:209-13.
109. Brunner EW, Jurewicz I, Heister E, Fahimi A, Bo C, Sear RP, et al. Growth and proliferation of human embryonic stem cells on fully synthetic scaffolds based on carbon nanotubes. ACS Appl Mater Interfaces 2014;6:2598-2603.
110. Weaver VM, Lelievre S, Lakins JN, Chrenek MA, Jones JC, Giancotti F, et al. B4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2002;2:205-16.
111. Comley J. Progress made in applying 3D cell culture technologies. Drug Discovery World 2013;41-58.
112. Funk D, Schrenk HH, Frei E. Serum albumin leads to falsepositive results in the XTT and the MTT assay. BioTechniques 2007;43:178-86.
113. Patri AK, Dobrovolskaia MA, Stern ST, McNeil SE. Nanotechnology for cancer therapy. New York: CRC Press; 2006. p. 105-38. ISBN: 978-0849371943.
114. Wörle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Letters 2006;6:1261-8.
115. Landsiedel R, Kapp MD, Schulz M, Wiench K, Oesch F. Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations -many questions, some answers. Mutat Res 2009;681:241-58.
116. Kisin ER, Murray AR, Keane MJ, Shi XC, Schwegler-Berry D, Gorelik O, et al. Single-walled carbon nanotubes: geno-And cytotoxic effects in lung fibroblast V79 cells. J Toxicol Environ Health A 2007;70:2071-9.
117. Balasubramanyam A, Sailaja N, Mahboob M, Rahman MF, Hussain SM, Grover P. In vitro mutagenicity assessment of aluminium oxide nanomaterials using the Salmonella/microsome assay. Toxicol In Vitro 2010;24:1871-6.
118. Balasubramanyam A, Sailaja N, Mahboob M, Rahman MF, Hussain SM, Grover P. In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test. Mutagenesis 2009;24:245-51.
119. Kim HR, Park YJ, Shin da Y, Oh SM, Chung KH. Appropriate in vitro methods for genotoxicity testing of silver nanoparticles. Environ Health Toxicol 2013;28:e2013003.
120. Blank F, Rothen-Rutishauser B, Schurch S, Gehr P. An optimized in vitro model of the respiratory tract wall to study particle cell interactions. J Aerosol Med 2006;19:392-405.
121. Schurch S, Gehr P, Im Hof V, Geiser M, Green F. Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Physiol 1990;80:17-32.
122. Tippe A, Heinzmann U, Roth C. Deposition of fi ne and ultrafine aerosol particles during exposure at the air/cell interface. Aerosol Sci 2002;33:207-18.
123. Aufderheide M, Mohr U. CULTEX -An alternative technique for cultivation and exposure of cells of the respiratory tract to airborne pollutants at the air/liquid interface. Exp Toxicol Pathol 2000;52:265-70.
124. Mahto SK, Yoon TH, Rhee SW. A new perspective on in vitro assessment method for evaluating quantum dot toxicity by using microfluidics technology. Biomicrofluidics 2010;4:pii:034111.
125. Roggen EL, Soni NK, Verheyen GR. Respiratory immunotoxicity: An in vitro assessment. Toxicol In Vitro 2006;20:1240-64.
126. Blank F, Rothen-Rutishauser B, Gehr P. Dendritic cells and macrophages form a transepithelial network against foreign particulate antigens. Am J Respir Cell Mol Biol 2007;36:669-77.
127. Lehmann AD, Daum N, Bur M, Lehr CM, Gehr P, Rothen-Rutishauser BM. An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. Eur J Pharm Biopharm 2011;77:398-406.
128. Grafmüller S, Manser P, Krug HF, Wick P, von Mandach U. Determination of the transport rate of xenobiotics and nanomaterials across the placenta using the ex vivo human placental perfusion model. J Vis Exp 2013;76:e50401.
129. Wick P, Malek A, Manser P, Meili D, Maeder-Althaus X, Diener L, et al. Barrier capacity of human placenta for nanosized materials. Environ Health Perspect 2010;118:432-6.
130. Leavens TL, Monteiro-Riviere NA, Inman AO, Brooks JD, Oldenburg SJ, Riviere JE. In vitro biodistribution of silver nanoparticles in isolated perfused porcine skin flaps. J Appl Toxicol 2012;32:913-9.
131. Deloison B, Siauve N, Aimot S, Balvay D, Thiam R, Cuenod CA, et al. SPIO-enhanced magnetic resonance imaging study of placental perfusion in a rat model of intrauterine growth restriction. BJOG 2012;119:626-33.
132. Leavens TL, Xia XR, Lee HA, Monteiro-Riviere NA, Brooks JD, Riviere JE. Evaluation of perfused porcine skin as a model system to quantitate tissue distribution of fullerene nanoparticles. Toxicol Lett 2010;197:1-6.
133. Lee HA, Imran M, Monteiro-Riviere NA, Colvin VL, Yu WW, Riviere JE. Biodistribution of quantum dot nanoparticles in perfused skin: evidence of coating dependency and periodicity in arterial extraction. Nano Lett 2007;7:2865-70.
134. Meiring JJ, Borm PJ, Bagate K, Semmler M, Seitz J, Takenaka S, et al. The influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lung. Part Fibre Toxicol 2005;2:3.
135. Klabusay M, Scheer P, Doubek M, Rehakova K, Coupek P, Horky D. Retention of nanoparticles-labeled bone marrow mononuclear cells in the isolated ex vivo perfused heart after myocardial infarction in animal model. Exp Biol Med (Maywood) 2009;234:222-31.
136. Avilés MO, Mangual JO, Ebner AD, Ritter JA. Isolated swine heart ventricle perfusion model for implant assisted-magnetic drug targeting. Int J Pharm 2008;361:202-8.
137. Zimmer CC, Liu YX, Morgan JT, Yang G, Wang KH, Kennedy IM, et al. New approach to investigate the cytotoxicity of nanomaterials using single cell mechanics. J Phys Chem B 2014;118:1246-55.
138. Place E, George J, Williams C, Stevens M. Synthetic polymer scaffolds for tissue engineering. Chem Soc Rev 2009;38:1139-51.
139. Dhaliwal A. Three dimensional cell culture: A review. Mater Methods 2012;2:162.
140. Härmä V, Virtanen J, Mäkelä R, Happonen A, Mpindi J, Knuuttila M, et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 2010;5:e10431.
141. Keller J, Brink S, Busse B, Schilling A, Schinke T, Amling M, et al. Divergent resorbability and effects on osteoclast formation of commonly used bone substitutes in a human in vitroassay. PLoS One 2012;7:e46757.
142. Catelas I, Sese N, Wu B, Dunn J, Helgerson S, Tawil B. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng 2006;12:2385-96.
143. Barber F, Herbert M, Coons D. Tendon augmentation grafts: biomechanical failure loads and failure patterns. Arthroscopy 2006;22:534-8.
144. Darr A, Calabro A. Synthesis and characterization of tyramine-based hyaluronan hydrogels. J Mater Sci Mater Med 2009;20:33-44.
145. Geiger M, Li R, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003;55:1613-29.
146. Friess W, Uludag H, Foskett S, Biron R. Bone regeneration with recombinant human bone morphogenetic protein-2 (rhBMP-2) using absorbable collagen sponges (ACS): influence of processing on ACS characteristics and formulation. Pharm Dev Technol 1999;4:387-96.
147. Hsu H, Zanella J, Peckham S, Spector M. Comparing ectopic bone growth induced by rhBMP-2 on an absorbable collagen sponge in rat and rabbit models. J Orthop Res 2006;24:1660-9.
148. Gerecht-Nir S, Cohen S, Ziskind A, Itskovitz-Eldor J. Threedimensional porous alginate scaffolds provide a conducive environment for generation of well-vascularized embryoid bodies from human embryonic stem cells. Biotechnol Bioeng 2004;88:313-20.
149. Dar A, Shachar M, Leor J, Cohen S. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng 2002;80:305-12.
150. Rowley J, Madlambayan G, Mooney D. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999;20:45-53.
151. Godugu C, Patel AR, Desai U, Andey T, Sams A, Singh M. AlgiMatrix based 3D cell culture system as an in-vitro tumor model for anticancer studies. PLoS One 2013;8:e53708.
152. Hanada S, Fujioka K, Inoue Y, Kanaya F, Manome Y, Yamamoto K. Cell-based in vitro blood-brain barrier model can rapidly evaluate nanoparticles brain permeability in association with particle size and surface modification. Int J Mol Sci 2014;15:1812-25.
153. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids Surf B 2008;66:274-80.
154. Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M, et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 2011;6:321-8.
155. Visiongain Report: "Cell-Based Assays: World Market Prospects" 2012-2022; March 2012.
156. BCC Research: Cell-Based Assays: Technologies and Global Markets, 2014.
157. Canesi L, Frenzilli G, Balbi T, Bernardeschi M, Ciacci C, Corsolini S, et al. Interactive effects of n-TiO2 and 2,3,7,8-TCDD on the marine bivalve Mytilus galloprovincialis. Aquat Toxicol 2013;pii:S0166-445X(13)00308-1.